# A Phase 1 Study of CLYM116 in Normal Healthy Volunteers

> **NCT07248865** · PHASE1 · RECRUITING · sponsor: **Climb Bio, Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CLYM116
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07248865
- **Lead sponsor:** Climb Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07248865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07248865, "A Phase 1 Study of CLYM116 in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07248865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*